PTLF (Petlife Pharmaceuticals) Institutional Ownership: 80.60% (As of Aug. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Petlife Pharmaceuticals Institutional Ownership?

Petlife Pharmaceuticals PTLF Institutional Ownership is 80.60% as of Aug. 16, 2026.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Petlife Pharmaceuticals's institutional ownership is 80.60%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Petlife Pharmaceuticals's Insider Ownership is 66.39%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Petlife Pharmaceuticals's Float Percentage Of Total Shares Outstanding is 97.65%.

Petlife Pharmaceuticals Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Petlife Pharmaceuticals's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Petlife Pharmaceuticals Institutional Ownership Chart

Petlife Pharmaceuticals Historical Data

The historical data trend for Petlife Pharmaceuticals can be seen below:

2012-11-30 2012-12-31
Institutional Ownership 85.53 80.60

Petlife Pharmaceuticals Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 80.60% mean?
Petlife Pharmaceuticals (PTLF) has a Institutional Ownership of 80.60% as of Aug. 16, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Petlife Pharmaceuticals and its competitors.
Is Petlife Pharmaceuticals' Institutional Ownership too high?
Petlife Pharmaceuticals' current Institutional Ownership is 80.60%.
How does Petlife Pharmaceuticals' Institutional Ownership compare to PCYN and YBAO?
Petlife Pharmaceuticals' Institutional Ownership of 80.60% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Drug Manufacturers company?
A good Institutional Ownership depends on the Drug Manufacturers industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Petlife Pharmaceuticals and its competitors. Petlife Pharmaceuticals's current Institutional Ownership is 80.60%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Petlife Pharmaceuticals stock overvalued right now?
Petlife Pharmaceuticals (PTLF) has a current Institutional Ownership of 80.60%. The current Institutional Ownership is 80.60%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Petlife Pharmaceuticals (PTLF), the current Institutional Ownership is 80.60% as of Aug. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Petlife Pharmaceuticals Business Description

Address 38 West Main Street, 6th Floor, Hancock, MD, USA, 21750
Petlife Pharmaceuticals Inc specializes in the research, development, sales, and support of advanced drugs and nutraceuticals for pet cancer and autoimmune related diseases such as arthritis. It develops potentiated veterinary cancer medications and nutraceuticals, under its tradename Vitalzul based on Escozine formula. The Vitalzul is a polarized, bioactive peptide extracted from the Blue Caribbean Scorpion (Rhopularus Princeps), which contains amino acids, proteins, and minerals.